Skip to main content
. 2021 Aug 18;7:71. doi: 10.1038/s41421-021-00315-9

Fig. 1. Production and characterization of recombinant monomeric RBD protein of SARS-CoV-2 in yeast.

Fig. 1

a Schematic diagram of the expression construct pPinkα-HC-RBD. PAOX1, AOX1 promoter; SP, signal peptide; CYC1 TT, CYC1 transcription termination region. b SDS-PAGE (left panel) and western blotting (WB; right panel) analysis of purified SARS-CoV-2 RBD protein. An anti-RBD (inclusion bodies) polyclonal antibody served as the detection antibody in WB assay. c Reactivity of yeast-derived RBD with neutralizing MAbs 2H2 and 3C1 determined by ELISA. BSA served as negative control. Data shown are means ± SEM of OD450 readings from triplicate wells. d Binding affinity of yeast-derived RBD to immobilized hACE2-Fc determined by BLI. RBD protein concentrations used were shown. e Inhibition of cell entry of SARS-CoV-2 pseudovirus (PV) by yeast-produced RBD protein. Data are means ± SEM of triplicate wells. Statistical significance was determined by Student’s t-test and indicated as follows: **P < 0.01; ***P < 0.001.